{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:43:48Z","timestamp":1790358228575,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jjcc.2014.06.009","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T09:45:35Z","timestamp":1406540735000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Treatment of idiopathic\/hereditary pulmonary arterial hypertension"],"prefix":"10.1016","volume":"64","author":[{"given":"Hiromi","family":"Matsubara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2014.06.009_bib0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0015","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL Registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0020","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jacc.2009.04.017","article-title":"Updated evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"54","author":"Barst","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1183\/09031936.00092311","article-title":"The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension","volume":"39","author":"Nickel","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.161.2.9906015","article-title":"Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing","volume":"161","author":"Miyamoto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0040","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1183\/09031936.00217911","article-title":"Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension","volume":"40","author":"Deboeck","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0045","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1183\/09031936.00134506","article-title":"Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension","volume":"29","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.0000022687.18568.2A","article-title":"Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing","volume":"106","author":"Wensel","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0055","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.160.2.9812078","article-title":"Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension","volume":"160","author":"Nagaya","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0065","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0735-1097(02)01744-8","article-title":"Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension","volume":"39","author":"Raymond","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0070","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","article-title":"Tricuspid annular displacement predicts survival in pulmonary hypertension","volume":"174","author":"Forfia","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0075","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","article-title":"Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension","volume":"28","author":"van Wolferen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0080","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","article-title":"Ambrisentan therapy for pulmonary arterial hypertension","volume":"46","author":"Galie","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0090","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0095","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0105","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0115","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0120","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","article-title":"Treatment goals of pulmonary hypertension","volume":"62","author":"McLaughlin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of \u03b2-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0130","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Galie","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1440-1681.2003.03879.x","article-title":"Cardiac energetics: from Emax to pressure\u2013volume area","volume":"30","author":"Suga","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0140","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/01.RES.56.4.586","article-title":"Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle","volume":"56","author":"Sunagawa","year":"1985","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.CIR.83.1.315","article-title":"Nonlinearity and load sensitivity of end-systolic pressure\u2013volume relation of canine left ventricle in vivo","volume":"83","author":"van der Velde","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0150","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1161\/01.CIR.0000143138.02493.DD","article-title":"Magnetic resonance imaging analysis of right ventricular pressure\u2013volume loops: in vivo validation and clinical application in patients with pulmonary hypertension","volume":"110","author":"Kuehne","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0155","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1183\/09031936.00135407","article-title":"Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension","volume":"31","author":"Overbeek","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0160","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/rccm.200611-1615OC","article-title":"How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension","volume":"175","author":"Kerbaul","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0165","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jacc.2012.01.083","article-title":"Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials","volume":"60","author":"Savarese","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0170","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0175","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.0000138104.83366.E9","article-title":"Outcomes in children with idiopathic pulmonary arterial hypertension","volume":"110","author":"Yung","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0185","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/ars.2008.2390","article-title":"Cyclic stretch, reactive oxygen species, and vascular remodeling","volume":"11","author":"Birukov","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1378\/chest.130.1.214","article-title":"Reversal of idiopathic pulmonary arterial hypertension and allograft pneumonectomy after single lung transplantation","volume":"130","author":"Deb","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1053-2498(00)00153-4","article-title":"Pathologic regression of primary pulmonary hypertension in left native lung following right single-lung transplantation","volume":"20","author":"Levy","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2014.06.009_bib0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"issue":"February","key":"10.1016\/j.jjcc.2014.06.009_bib0205","article-title":"Long-term patient survival with idiopathic\/heritable pulmonary arterial hypertension treated at a single center in Japan","author":"Ogawa","year":"2014","journal-title":"Life Sci"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871400183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871400183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:53:04Z","timestamp":1760273584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450871400183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S091450871400183X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2014.06.009","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of idiopathic\/hereditary pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2014.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}